Qinghai Ji

2.3k total citations
86 papers, 1.6k citations indexed

About

Qinghai Ji is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, Qinghai Ji has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Oncology and 30 papers in Surgery. Recurrent topics in Qinghai Ji's work include Thyroid Cancer Diagnosis and Treatment (43 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Head and Neck Cancer Studies (14 papers). Qinghai Ji is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (43 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Head and Neck Cancer Studies (14 papers). Qinghai Ji collaborates with scholars based in China, United States and Russia. Qinghai Ji's co-authors include Zhong‐Wu Lu, Ben Ma, Ning Qu, Yongxue Zhu, Tian Liao, Wenjun Wei, Zhuoying Wang, Yulong Wang, Rong‐Liang Shi and Duanshu Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Qinghai Ji

83 papers receiving 1.5k citations

Peers

Qinghai Ji
Qinghai Ji China
Ning Qu China
Abigail I. Wald United States
Oskar Koperek Austria
Maria Rossing Denmark
Yvan C. Bédard Canada
Maria Cláudia Nogueira Zerbini Brazil
Lenine Garcia Brandão Brazil
Jin Hee Sohn South Korea
Darcy A. Kerr United States
Qinghai Ji China
Qinghai Ji
Citations per year, relative to Qinghai Ji Qinghai Ji (= 1×) peers Qinghai Ji

Countries citing papers authored by Qinghai Ji

Since Specialization
Citations

This map shows the geographic impact of Qinghai Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghai Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghai Ji more than expected).

Fields of papers citing papers by Qinghai Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghai Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghai Ji. The network helps show where Qinghai Ji may publish in the future.

Co-authorship network of co-authors of Qinghai Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghai Ji. A scholar is included among the top collaborators of Qinghai Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghai Ji. Qinghai Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Dongmei, Yanjing Guo, Xin Liu, et al.. (2024). A phase II umbrella clinical trial of advanced salivary gland cancer based on molecular typing.. Journal of Clinical Oncology. 42(16_suppl). e18062–e18062. 2 indexed citations
2.
Zhang, Tingting, Yunjun Wang, Yan Zhang, et al.. (2024). Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data. EClinicalMedicine. 77. 102912–102912. 4 indexed citations
3.
4.
Chen, Jiaying, Naisi Huang, Wenjun Wei, et al.. (2023). The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study. Annals of Surgical Oncology. 30(12). 7172–7180. 17 indexed citations
5.
Yu, Pengcheng, Ning Qu, Rui Zhu, et al.. (2023). TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. Science Advances. 9(35). eadg7125–eadg7125. 39 indexed citations
6.
Ma, Ben, Yi Luo, Yichen Yang, et al.. (2022). Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 108(2). 368–384. 9 indexed citations
7.
Zheng, Xiangqian, Zhengang Xu, Qinghai Ji, et al.. (2021). A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Cancer Research. 27(20). 5502–5509. 31 indexed citations
8.
Tan, Licheng, Wanlin Liu, Xiaoli Zhu, et al.. (2021). Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules. Frontiers in Oncology. 11. 677892–677892. 6 indexed citations
9.
Xu, Weibo, Cuiwei Li, Ben Ma, et al.. (2021). Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer. Frontiers in Oncology. 11. 641851–641851. 5 indexed citations
10.
11.
Qu, Ning, Xiao Shi, Jingjing Zhao, et al.. (2020). Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma. Thyroid. 30(7). 1025–1036. 14 indexed citations
12.
13.
Hu, Jia‐Qian, Duo Wen, Ben Ma, et al.. (2020). IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro. Journal of Cancer. 11(14). 4250–4260. 17 indexed citations
14.
15.
Qu, Ning, Rong‐Liang Shi, Tian Liao, et al.. (2019). Germline Missense Mutation of Deleted in Malignant Brain Tumor 1 (<b><i>DMBT1</i></b>) in Familial Mediastinal Neuroendocrine Cancer and in vitro Effects in Thyroid Cancer Cells. Neuroendocrinology. 110(7-8). 714–720. 1 indexed citations
16.
Qian, Kai, Kai Guo, Xiaoke Zheng, et al.. (2018). The limited role of elective neck dissection in patients with cN0 salivary gland carcinoma. Journal of Cranio-Maxillofacial Surgery. 47(1). 47–52. 10 indexed citations
17.
Ji, Qinghai, et al.. (2018). Impact of tumor dimensions and lymph node density on the survival of patients with hypopharyngeal squamous cell carcinoma. Cancer Management and Research. Volume 10. 4679–4688. 8 indexed citations
18.
Sun, Guohua, Ning Qu, Jia‐Qian Hu, et al.. (2017). [Risk for metastasis of lymph node between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer].. PubMed. 52(4). 253–258. 4 indexed citations
19.
Ma, Ben, Tian Liao, Duo Wen, et al.. (2016). Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer. Scientific Reports. 6(1). 36973–36973. 40 indexed citations
20.
Zhu, Guanhua, et al.. (2013). Lymph node ratio as a survival risk factor for oropharyngeal squamous cell carcinoma patients with lymph node metastasis: A SEER-based analysis. Head & Neck Oncology. 5(3). 8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinghai Ji Breakdown of academic impact, for papers by Ning Qu Breakdown of academic impact, for papers by Abigail I. Wald Breakdown of academic impact, for papers by Oskar Koperek Breakdown of academic impact, for papers by Maria Rossing Breakdown of academic impact, for papers by Yvan C. Bédard Breakdown of academic impact, for papers by Maria Cláudia Nogueira Zerbini Breakdown of academic impact, for papers by Lenine Garcia Brandão Breakdown of academic impact, for papers by Jin Hee Sohn Breakdown of academic impact, for papers by Darcy A. Kerr
Rankless by CCL
2026